Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.96 |
High Similarity |
NPD252 |
Clinical (unspecified phase) |
0.9365 |
High Similarity |
NPD194 |
Clinical (unspecified phase) |
0.92 |
High Similarity |
NPD9632 |
Phase 3 |
0.9154 |
High Similarity |
NPD549 |
Approved |
0.8633 |
High Similarity |
NPD3086 |
Phase 3 |
0.8561 |
High Similarity |
NPD3085 |
Phase 1 |
0.8548 |
High Similarity |
NPD9607 |
Approved |
0.8468 |
Intermediate Similarity |
NPD9606 |
Approved |
0.8456 |
Intermediate Similarity |
NPD582 |
Approved |
0.8276 |
Intermediate Similarity |
NPD4074 |
Clinical (unspecified phase) |
0.8271 |
Intermediate Similarity |
NPD209 |
Clinical (unspecified phase) |
0.8226 |
Intermediate Similarity |
NPD9374 |
Approved |
0.811 |
Intermediate Similarity |
NPD307 |
Approved |
0.8065 |
Intermediate Similarity |
NPD9373 |
Approved |
0.806 |
Intermediate Similarity |
NPD545 |
Clinical (unspecified phase) |
0.7943 |
Intermediate Similarity |
NPD250 |
Approved |
0.7943 |
Intermediate Similarity |
NPD249 |
Approved |
0.7931 |
Intermediate Similarity |
NPD536 |
Clinical (unspecified phase) |
0.7926 |
Intermediate Similarity |
NPD547 |
Clinical (unspecified phase) |
0.7832 |
Intermediate Similarity |
NPD186 |
Discovery |
0.7832 |
Intermediate Similarity |
NPD195 |
Approved |
0.773 |
Intermediate Similarity |
NPD1431 |
Approved |
0.773 |
Intermediate Similarity |
NPD1430 |
Approved |
0.7718 |
Intermediate Similarity |
NPD220 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD216 |
Approved |
0.7718 |
Intermediate Similarity |
NPD219 |
Phase 3 |
0.7718 |
Intermediate Similarity |
NPD218 |
Approved |
0.7718 |
Intermediate Similarity |
NPD217 |
Approved |
0.7676 |
Intermediate Similarity |
NPD185 |
Approved |
0.7655 |
Intermediate Similarity |
NPD775 |
Approved |
0.7635 |
Intermediate Similarity |
NPD213 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD1369 |
Phase 2 |
0.7635 |
Intermediate Similarity |
NPD214 |
Approved |
0.7635 |
Intermediate Similarity |
NPD1750 |
Clinical (unspecified phase) |
0.7634 |
Intermediate Similarity |
NPD9409 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD283 |
Approved |
0.76 |
Intermediate Similarity |
NPD2624 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD166 |
Approved |
0.7559 |
Intermediate Similarity |
NPD9375 |
Discontinued |
0.7535 |
Intermediate Similarity |
NPD193 |
Suspended |
0.7517 |
Intermediate Similarity |
NPD242 |
Approved |
0.7517 |
Intermediate Similarity |
NPD3107 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD338 |
Approved |
0.7483 |
Intermediate Similarity |
NPD2646 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD1732 |
Phase 3 |
0.7467 |
Intermediate Similarity |
NPD339 |
Approved |
0.7417 |
Intermediate Similarity |
NPD169 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD1808 |
Phase 1 |
0.7383 |
Intermediate Similarity |
NPD353 |
Discontinued |
0.7376 |
Intermediate Similarity |
NPD1121 |
Approved |
0.7376 |
Intermediate Similarity |
NPD1120 |
Approved |
0.7372 |
Intermediate Similarity |
NPD247 |
Clinical (unspecified phase) |
0.7348 |
Intermediate Similarity |
NPD237 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD515 |
Phase 1 |
0.7248 |
Intermediate Similarity |
NPD548 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD9605 |
Phase 3 |
0.7121 |
Intermediate Similarity |
NPD9584 |
Phase 2 |
0.709 |
Intermediate Similarity |
NPD9360 |
Approved |
0.703 |
Intermediate Similarity |
NPD4716 |
Approved |
0.7 |
Intermediate Similarity |
NPD2647 |
Phase 3 |
0.6988 |
Remote Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD7842 |
Phase 2 |
0.689 |
Remote Similarity |
NPD5666 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD8837 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD798 |
Discontinued |
0.6832 |
Remote Similarity |
NPD7988 |
Suspended |
0.6822 |
Remote Similarity |
NPD9626 |
Clinical (unspecified phase) |
0.6805 |
Remote Similarity |
NPD1692 |
Approved |
0.6783 |
Remote Similarity |
NPD248 |
Discontinued |
0.6769 |
Remote Similarity |
NPD9291 |
Approved |
0.6747 |
Remote Similarity |
NPD4171 |
Clinical (unspecified phase) |
0.6744 |
Remote Similarity |
NPD2152 |
Clinical (unspecified phase) |
0.6728 |
Remote Similarity |
NPD1776 |
Approved |
0.6728 |
Remote Similarity |
NPD1777 |
Approved |
0.6718 |
Remote Similarity |
NPD1816 |
Clinical (unspecified phase) |
0.6709 |
Remote Similarity |
NPD546 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD1412 |
Clinical (unspecified phase) |
0.6643 |
Remote Similarity |
NPD870 |
Clinical (unspecified phase) |
0.6584 |
Remote Similarity |
NPD516 |
Clinical (unspecified phase) |
0.6543 |
Remote Similarity |
NPD3083 |
Approved |
0.6532 |
Remote Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.6532 |
Remote Similarity |
NPD6417 |
Clinical (unspecified phase) |
0.6532 |
Remote Similarity |
NPD5682 |
Phase 3 |
0.6532 |
Remote Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.6514 |
Remote Similarity |
NPD4054 |
Clinical (unspecified phase) |
0.6457 |
Remote Similarity |
NPD2630 |
Approved |
0.6457 |
Remote Similarity |
NPD2632 |
Approved |
0.6457 |
Remote Similarity |
NPD2631 |
Clinical (unspecified phase) |
0.6418 |
Remote Similarity |
NPD9416 |
Phase 3 |
0.6418 |
Remote Similarity |
NPD9417 |
Phase 3 |
0.6403 |
Remote Similarity |
NPD1368 |
Approved |
0.64 |
Remote Similarity |
NPD7138 |
Phase 2 |
0.6284 |
Remote Similarity |
NPD282 |
Approved |
0.6275 |
Remote Similarity |
NPD1118 |
Discontinued |
0.6267 |
Remote Similarity |
NPD1119 |
Phase 2 |
0.6226 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.619 |
Remote Similarity |
NPD1354 |
Approved |
0.619 |
Remote Similarity |
NPD1355 |
Clinical (unspecified phase) |
0.619 |
Remote Similarity |
NPD1356 |
Approved |
0.6149 |
Remote Similarity |
NPD9633 |
Phase 3 |
0.6139 |
Remote Similarity |
NPD7531 |
Clinical (unspecified phase) |
0.6129 |
Remote Similarity |
NPD2253 |
Discontinued |
0.6115 |
Remote Similarity |
NPD7158 |
Phase 1 |
0.6091 |
Remote Similarity |
NPD6381 |
Phase 2 |
0.6054 |
Remote Similarity |
NPD9408 |
Phase 3 |
0.6049 |
Remote Similarity |
NPD231 |
Clinical (unspecified phase) |
0.6032 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.6032 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.6028 |
Remote Similarity |
NPD9406 |
Approved |
0.598 |
Remote Similarity |
NPD6036 |
Suspended |
0.5979 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.5973 |
Remote Similarity |
NPD1127 |
Approved |
0.5973 |
Remote Similarity |
NPD1128 |
Approved |
0.5969 |
Remote Similarity |
NPD2824 |
Phase 2 |
0.5968 |
Remote Similarity |
NPD5665 |
Clinical (unspecified phase) |
0.5952 |
Remote Similarity |
NPD5768 |
Phase 2 |
0.5946 |
Remote Similarity |
NPD281 |
Approved |
0.5926 |
Remote Similarity |
NPD1061 |
Clinical (unspecified phase) |
0.5909 |
Remote Similarity |
NPD1046 |
Clinical (unspecified phase) |
0.5904 |
Remote Similarity |
NPD2604 |
Approved |
0.5886 |
Remote Similarity |
NPD1117 |
Clinical (unspecified phase) |
0.5875 |
Remote Similarity |
NPD1730 |
Discontinued |
0.5839 |
Remote Similarity |
NPD4812 |
Phase 1 |
0.5808 |
Remote Similarity |
NPD3697 |
Discontinued |
0.5806 |
Remote Similarity |
NPD535 |
Approved |
0.5789 |
Remote Similarity |
NPD8829 |
Clinical (unspecified phase) |
0.5783 |
Remote Similarity |
NPD2180 |
Approved |
0.5779 |
Remote Similarity |
NPD9083 |
Clinical (unspecified phase) |
0.5772 |
Remote Similarity |
NPD9429 |
Discontinued |
0.5772 |
Remote Similarity |
NPD9084 |
Phase 2 |
0.5767 |
Remote Similarity |
NPD4599 |
Clinical (unspecified phase) |
0.5744 |
Remote Similarity |
NPD4495 |
Phase 1 |
0.5736 |
Remote Similarity |
NPD9102 |
Approved |
0.5736 |
Remote Similarity |
NPD9103 |
Approved |
0.5723 |
Remote Similarity |
NPD1731 |
Clinical (unspecified phase) |
0.5714 |
Remote Similarity |
NPD1063 |
Phase 2 |
0.5704 |
Remote Similarity |
NPD223 |
Clinical (unspecified phase) |
0.5691 |
Remote Similarity |
NPD691 |
Discontinued |
0.5685 |
Remote Similarity |
NPD578 |
Discontinued |
0.5685 |
Remote Similarity |
NPD2903 |
Clinical (unspecified phase) |
0.5685 |
Remote Similarity |
NPD2902 |
Phase 2 |
0.566 |
Remote Similarity |
NPD3696 |
Approved |
0.566 |
Remote Similarity |
NPD3695 |
Approved |
0.5649 |
Remote Similarity |
NPD9585 |
Discontinued |
0.564 |
Remote Similarity |
NPD527 |
Clinical (unspecified phase) |
0.5639 |
Remote Similarity |
NPD8838 |
Approved |
0.5638 |
Remote Similarity |
NPD8830 |
Phase 3 |
0.5617
|
Remote Similarity |
NPD171 |
Discontinued |